| Patient | Cleopatra |
|---|---|
| Date of birth | 1997-01-15 |
| Identifiers | MRN HR-AC003-SYN; SSN (made up) 000-03-7095 |
| Document date | 2026-03-17 |
| Author | Samira Haddad-Thornbury, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Second pregnancy at 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size and heavier nausea than in her first pregnancy. Please perform a first-trimester ultrasound at 11 weeks to establish the dates and the cause of the large uterus, and advise on her prenatal care. [S]
Urgency: Routine, within two weeks; sooner for bleeding, pain, or severe vomiting. [S]
Questions for the consultant:
Cleopatra is seen at the request of Dr. Arvanitis-Osei at 11 weeks 0 days. Her first pregnancy, seven years ago, went to term without complications, by her account, with a vaginal birth. She has regular cycles and a certain last period. Nausea has eased on doxylamine with pyridoxine. No bleeding or pain. No family history of twins that she knows of and no fertility treatment. She leads a demanding business and wants to keep working; she prefers clear plans and women clinicians. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-03 | active | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning with water or orange juice, apart from tea, coffee, and calcium | Oral route | 2026-03-03 | active | S |
| Doxylamine succinate 10 mg / pyridoxine hydrochloride 10 mg delayed-release tablet, two tablets by mouth at bedtime | Two tablets at bedtime; may add one in the morning if needed | Oral route | 2026-03-03 to 2026-05-12 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Uterus larger than dates in early pregnancy: 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size; nausea and vomiting heavier than in her first pregnancy; no bleeding; cause not yet known (multiple pregnancy, dating error, fibroids, or molar pregnancy) | resolved | confirmed | O26.841 | S — Synthetic presenting finding anchored to the documented conception in the winter of 41 to 40 BC; it resolves when the ultrasound explains it. |
| Nausea and vomiting of pregnancy, moderate (PUQE score 9); keeping fluids down; no weight loss or ketonuria | active | confirmed | O21.9 | S — Synthetic; nausea is common and often heavier in early pregnancy with a large uterus. |
| Iron deficiency anemia in pregnancy: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mL | active | confirmed | O99.011 | S — Synthetic finding; it echoes no documented diagnosis. |
| Twin pregnancy, dichorionic diamniotic, second pregnancy (gravida 2, para 1): two live fetuses with a thick dividing membrane and a twin-peak (lambda) sign at 11 weeks; dated by her last period, confirmed by the crown-rump lengths | active | confirmed | O30.041 | S — Synthetic modern diagnosis anchored to the documented twins of 40 BC; chorionicity is a modern finding and makes no claim about her real pregnancy. |
Vital signs recorded on 2026-03-17; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Abdomen | Uterus about 14 weeks in size; non-tender |
| Ultrasound | Two fetal hearts, 162 and 158 per minute |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-17 | Fetal Crown Rump length US | 45 | mm | Consistent with 11 weeks 2 days | Normal | S |
| 2026-03-17 | Fetal Crown Rump length US | 46 | mm | Consistent with 11 weeks 3 days | Normal | S |
| 2026-03-17 | Fetal nuchal translucency measured by US | 1.6 | mm | <=3.5 mm | Normal | S |
| 2026-03-17 | Fetal nuchal translucency measured by US | 1.8 | mm | <=3.5 mm | Normal | S |
Data reviewed: Today's first-trimester ultrasound: two live intrauterine fetuses; a thick dividing membrane meeting a fused anterior placental mass in a twin-peak (lambda) sign; crown-rump lengths 45 mm (11 weeks 2 days) and 46 mm (11 weeks 3 days); nuchal translucency 1.6 and 1.8 mm; nasal bones present; no structural abnormality seen; no fibroids; normal ovaries; no features of a molar pregnancy. First-visit tests: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mL; hCG 152,000 mIU/mL; blood group A RhD positive, antibody screen negative; rubella immune; hepatitis B, HIV, syphilis, and hepatitis C negative; urine culture no growth. Today's blood pressure 106/64 mmHg and weight 58.2 kg. [S]